These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 9097752)

  • 1. Determining progressive visual field loss in serial Humphrey visual fields.
    Birch MK; Wishart PK; O'Donnell NP
    Ophthalmology; 1995 Aug; 102(8):1227-34; discussion 1234-5. PubMed ID: 9097752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of visual field progression in glaucoma: a comparison of PROGRESSOR and STATPAC 2.
    Viswanathan AC; Fitzke FW; Hitchings RA
    Br J Ophthalmol; 1997 Dec; 81(12):1037-42. PubMed ID: 9497460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is visual field evaluation using multiple correlations and linear regressions useful? An evaluation of Delphi perimetry.
    Wishart PK; Wardrop DR; Kosmin AS
    Graefes Arch Clin Exp Ophthalmol; 1998 Jul; 236(7):493-500. PubMed ID: 9672794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of five methods for estimating general glaucomatous visual field depression.
    Funkhouser A; Flammer J; Fankhauser F; Hirsbrunner HP
    Graefes Arch Clin Exp Ophthalmol; 1992; 230(2):101-6. PubMed ID: 1577286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infrequent confirmation of visual field progression.
    Lee AC; Sample PA; Blumenthal EZ; Berry C; Zangwill L; Weinreb RN
    Ophthalmology; 2002 Jun; 109(6):1059-65. PubMed ID: 12045044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blue-on-yellow perimetry can predict the development of glaucomatous visual field loss.
    Johnson CA; Adams AJ; Casson EJ; Brandt JD
    Arch Ophthalmol; 1993 May; 111(5):645-50. PubMed ID: 8489447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of early glaucomatous visual field loss as detected by blue-on-yellow and standard white-on-white automated perimetry.
    Johnson CA; Adams AJ; Casson EJ; Brandt JD
    Arch Ophthalmol; 1993 May; 111(5):651-6. PubMed ID: 8489448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Visual Field Progression be Predicted by Confocal Scanning Laser Ophthalmoscopic Imaging of the Optic Nerve Head in Glaucoma? (An American Ophthalmological Society Thesis).
    Danias J; Serle J
    Trans Am Ophthalmol Soc; 2015; 113():T4. PubMed ID: 26549913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-wavelength automated perimetry in low-, medium-, and high-risk ocular hypertensive eyes. Initial baseline results.
    Johnson CA; Brandt JD; Khong AM; Adams AJ
    Arch Ophthalmol; 1995 Jan; 113(1):70-6. PubMed ID: 7826296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of reliability with reproducibility of the glaucomatous visual field.
    McMillan TA; Stewart WC; Hunt HH
    Acta Ophthalmol (Copenh); 1992 Oct; 70(5):665-70. PubMed ID: 1471493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 24-2 Faster, Fast, and Standard Programs of Swedish Interactive Threshold Algorithm of Humphrey Field Analyzer for Perimetry in Patients With Manifest and Suspect Glaucoma.
    Thulasidas M; Patyal S
    J Glaucoma; 2020 Nov; 29(11):1070-1076. PubMed ID: 32890104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordance of parapapillary chorioretinal atrophy in ocular hypertension with visual field defects that accompany glaucoma development.
    Tezel G; Dorr D; Kolker AE; Wax MB; Kass MA
    Ophthalmology; 2000 Jun; 107(6):1194-9. PubMed ID: 10857843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glaucoma Progression Analysis software compared with expert consensus opinion in the detection of visual field progression in glaucoma.
    Tanna AP; Budenz DL; Bandi J; Feuer WJ; Feldman RM; Herndon LW; Rhee DJ; Whiteside-de Vos J; Huang J; Anderson DR
    Ophthalmology; 2012 Mar; 119(3):468-73. PubMed ID: 22137043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of visual field progression in glaucoma.
    Fitzke FW; Hitchings RA; Poinoosawmy D; McNaught AI; Crabb DP
    Br J Ophthalmol; 1996 Jan; 80(1):40-8. PubMed ID: 8664231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse visual field loss and glaucoma.
    Asman P; Heijl A
    Acta Ophthalmol (Copenh); 1994 Jun; 72(3):303-8. PubMed ID: 7976259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in St. Lucia, West Indies.
    Wilson MR; Kosoko O; Cowan CL; Sample PA; Johnson CA; Haynatzki G; Enger C; Crandall D
    Am J Ophthalmol; 2002 Sep; 134(3):399-405. PubMed ID: 12208252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of objective perimetry using multifocal visual evoked potentials in glaucoma practice.
    Graham SL; Klistorner AI; Goldberg I
    Arch Ophthalmol; 2005 Jun; 123(6):729-39. PubMed ID: 15955974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of visual field in patients with primary open-angle glaucoma - ProgF study 1.
    Aptel F; Aryal-Charles N; Giraud JM; El Chehab H; Delbarre M; Chiquet C; Romanet JP; Renard JP
    Acta Ophthalmol; 2015 Dec; 93(8):e615-20. PubMed ID: 26095771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating progression of visual field loss in glaucoma.
    Katz J; Gilbert D; Quigley HA; Sommer A
    Ophthalmology; 1997 Jun; 104(6):1017-25. PubMed ID: 9186444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selecting visual field tests and assessing visual field deterioration in glaucoma.
    Nouri-Mahdavi K
    Can J Ophthalmol; 2014 Dec; 49(6):497-505. PubMed ID: 25433738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.